This Startup Believes Our Genes Can Help Predict Severe COVID-19 Cases
October 27, 2020 | Ellen Glover
Founded in 2016, GoodCell collects users’ blood samples, then breaks them down to their cellular, DNA and plasma components. The DNA is tested for genetic predispositions to diseases, then the information and samples are stored in a biorepository for any future testing. The company says individuals retain both ownership and control over their own samples for clinical and research purposes.